Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Globalization, TRIPS and Access to Pharmaceuticals - WHO Policy Perspectives on Medicines, No. 003, March 2001
(2001; 6 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentA new era in global trade
View the documentKey requirements of the TRIPS Agreement
View the documentPublic health and TRIPS
View the documentEvaluating impacts of trade agreements
View the documentWHO perspectives on access to drugs
View the documentFurther reading
View the documentContacts at WHO Headquarters:

Contacts at WHO Headquarters:

Essential Drugs and Medicines Policy
Health Technology and Pharmaceuticals Cluster

WHO Headquarters, Geneva, Switzerland:

Dr Jonathan Quick
Director, Essential Drugs and Medicines
Policy Department.
Tel: +41 22 791 4443.
Email: quickj@who.int

Dr Hans Hogerzeil
Team Coordinator, Policy, Access and Rational Use
Tel: +41 22 791 3528
Email: hogerzeilh@who.int

Dr Lembit Rägo
Team Coordinator, Quality and Safety:
Tel: +41 22 791 4420
Email: ragol@who.int

Dr Germán Velásquez
Team Coordinator, Drug Action Programme
Tel: +41 22 791 3509
Email: velasquezg@who.int

Dr Xiaorui Zhang
Acting Team Coordinator, Traditional
Tel: +41 22 791 3639
Email: zhangx@who.int

© World Health Organization 2001

This document is not a formal publication of the World Health Organization (WHO), and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes. The views expressed in documents by named authors are solely the responsibility of those authors.

to previous section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017